Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes
Open Access
- 1 June 2006
- journal article
- Published by Elsevier BV
- Vol. 281 (26), 18081-18089
- https://doi.org/10.1074/jbc.m513640200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Integration of G protein signals by extracellular signal‐regulated protein kinases in SK‐N‐MC neuroepithelioma cellsJournal of Neurochemistry, 2005
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- Salvinorin A, an Active Component of the Hallucinogenic SageSalvia divinorumIs a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional ConsiderationsJournal of Pharmacology and Experimental Therapeutics, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- β-Arrestin2 Is Critically Involved in CXCR4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of p38 MAPK ActivationPublished by Elsevier BV ,2002
- Integration of Signals from Receptor Tyrosine Kinases and G Protein-Coupled ReceptorsNeurosignals, 2002
- Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptorsNature Reviews Neuroscience, 2001
- Involvement of Protein Kinase C and Src Family Tyrosine Kinase in Gαq/11-induced Activation of c-Jun N-terminal Kinase and p38 Mitogen-activated Protein KinasePublished by Elsevier BV ,1998
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor: STUDY OF Lck- AND FynT-DEPENDENT T CELL ACTIVATIONJournal of Biological Chemistry, 1996